Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. is a Private limited company (Ltd.) registered in South Korea under 1108608069, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Seoul, South Korea. 5 shareholders are on record for Chong Kun Dang Pharmaceutical Corp., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Chong Kun Dang Pharmaceutical Corp., filed with Supreme Court Internet Registry (IROS).
The largest of these is iShares Core MSCI Emerging Markets ETF, holding 20.7% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 15.4%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| iShares Core MSCI Emerging Markets ETF | 20.7% | Supreme Court Internet Registry (IROS) | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 15.4% | Supreme Court Internet Registry (IROS) | |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 8% | Supreme Court Internet Registry (IROS) | |
| Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 3.5% | Supreme Court Internet Registry (IROS) | |
| Schwab Strategic Tr-Schwab Fundamental Intl Small Company Idx ETF | 3% | Supreme Court Internet Registry (IROS) |
Officers
1
One officer is currently on record for Chong Kun Dang Pharmaceutical Corp., filed with Supreme Court Internet Registry (IROS). Young-joo Kim serves as President, Ceo & Chairman.
Management authority at Chong Kun Dang Pharmaceutical Corp. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Chong Kun Dang Pharmaceutical Corp. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans South Korea, Indonesia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Chong Kun Dang Pharmaceutical Corp.
South Korea
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Chong Kun Dang Pharmaceutical Corp.?
Five shareholders are currently on record for Chong Kun Dang Pharmaceutical Corp., filed with Supreme Court Internet Registry (IROS). The largest of these is iShares Core MSCI Emerging Markets ETF, holding 20.7% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 15.4%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Chong Kun Dang Pharmaceutical Corp.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Chong Kun Dang Pharmaceutical Corp. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Chong Kun Dang Pharmaceutical Corp. have on record?
5 shareholders are shown on record for Chong Kun Dang Pharmaceutical Corp.. The register reports 10 in total; only the top 5 by holding are shown here.
What is Chong Kun Dang Pharmaceutical Corp.'s company registration number?
Chong Kun Dang Pharmaceutical Corp.'s registration number is 1108608069, filed with Supreme Court Internet Registry (IROS) in South Korea. Its current status on the register is active.
Is Chong Kun Dang Pharmaceutical Corp. still an active company?
Chong Kun Dang Pharmaceutical Corp.'s status on Supreme Court Internet Registry (IROS) is listed as active.
What is Chong Kun Dang Pharmaceutical Corp.'s registered address?
The registered address on file for Chong Kun Dang Pharmaceutical Corp. is Seoul, South Korea.
What legal structure is Chong Kun Dang Pharmaceutical Corp. registered as?
Chong Kun Dang Pharmaceutical Corp. is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Chong Kun Dang Pharmaceutical Corp.?
One officer is currently on record for Chong Kun Dang Pharmaceutical Corp., filed with Supreme Court Internet Registry (IROS). Young-joo Kim serves as President, Ceo & Chairman. Management authority at Chong Kun Dang Pharmaceutical Corp. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Chong Kun Dang Pharmaceutical Corp. have a parent company or subsidiaries?
Chong Kun Dang Pharmaceutical Corp. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans South Korea, Indonesia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Chong Kun Dang Pharmaceutical Corp.'s ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Chong Kun Dang Pharmaceutical Corp.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Chong Kun Dang Pharmaceutical Corp.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Chong Kun Dang Pharmaceutical Corp.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 28 September 2026.